On Nov. 15, the U.S. Food and Drug Administration (FDA) granted a new indication to an electric stimulation device (NSS-2 Bridge) for use in helping to reduce the symptoms of opioid withdrawal. Read more via Fda.gov.
![fda opioid withdrawal symptom](https://www.myamericannurse.com/wp-content/uploads/2017/11/fda-opioid-withdrawal-symptom.jpg)
FDA permits marketing of device to help reduce opioid withdrawal symptoms
Share